CRO NACE Rev. 2 74.90 in IE. Official registry identity, source coverage and the current valuation evidence status on one public company profile.
ALPEX PHARMA (IRL) LIMITED has public figures, but the legal status or filing freshness makes an automated going-concern multiple misleading. Verify current continuity and owner context before showing a range.
Create a free account to add verified turnover, normalised EBITDA, debt and one-offs for ALPEX PHARMA (IRL) LIMITED in a private workspace.
We keep this public page conservative, so weak filings never become a false price.The page can still show filed facts, but the automatic public range is blocked when those facts would make the multiple misleading.
Operating as a CRO NACE Rev. 2 74.90, ALPEX PHARMA (IRL) LIMITED is registered in Ireland. The company was founded in 2018, incorporated as a LTD - Private Company Limited by Shares.
ALPEX PHARMA (IRL) LIMITED is listed in Irish Companies Registration Office (CRO) under registry number 634531.
Within the Irish NACE 74.90 cluster, public-record data is filed annually via the national company registry.
The most recent annual filing covers 2023 (period end 2023-07-31).
The benchmark is refreshed from governed Tier A/B peer distributions and is labelled separately from the source facts for ALPEX PHARMA (IRL) LIMITED.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
ALPEX PHARMA (IRL) LIMITED was founded in 2018 and is registered with Irish Companies Registration Office (CRO), incorporated as a LTD - Private Company Limited by Shares.
ALPEX PHARMA (IRL) LIMITED is registered under NACE 74.90: CRO NACE Rev. 2 74.90. That places the business within the Irish cluster for this activity.
The most recently filed annual accounts cover fiscal year 2023 (period end 2023-07-31), publicly available via Irish Companies Registration Office (CRO).
This page shows official or licensed public company facts and valuation-readiness context for ALPEX PHARMA (IRL) LIMITED; it does not show an automated public valuation range. The available facts may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
